EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
Go back to EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch| Becton Dickinson (NYSE: BDX) | Delayed: 181.95 +1.25 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $180.70 | 52 Week High | $181.76 | |||
| Open | $182.40 | 52 Week Low | $129.50 | |||
| Day High | $182.83 | P/E | 38.80 | |||
| Day Low | $180.75 | EPS | $4.69 | |||
| Volume | 385,703 | |||||
